| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 6, 2026 | Alentis and CSL enter USD 1.6 billion partnership |
CSL and Alentis Therapeutics announced they have entered into an exclusive global collaboration agreement to co-develop and co-promote lixudebart, which has the potential to become a first-in-class therapy targeting claudin-1 across a rang... |
| Oct 5, 2026 | CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases | Alentis to receive US$355 million initial payment and up to US$1.2 billion in commercial milestones, with global profits shared
MELBOURNE, Australia and BASEL, Switzerland, Oct. 5, 2026 /PRNewswire/ -- CSL and Alentis Therapeutics today ann... |
| Sep 11, 2026 | Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults | Phase 3 study demonstrates benefits of the first influenza vaccine to combine three proven approaches to enhancing protection for older adults in a single vaccine.
MAIDENHEAD, United Kingdom, Sept. 11, 2026 /PRNewswire/ -- CSL Seqirus, a bu... |
| Jul 1, 2026 | Ipsen to acquire Memo Therapeutics for up to EUR 700 million |
French biopahram company Ipsen and Schlieren-based Memo Therapeutics AG announced today they have entered into a definitive share purchase agreement under which Ipsen has agreed to acquire all issued and outstanding shares of Memo Therapeu... |
| Jun 26, 2026 | CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union | Recommendation follows an Article 20 non-pharmacovigilance procedure
Patients currently on TAVNEOS treatment should consult their treating physician
ST. GALLEN, Switzerland, June 26, 2026 /PRNewswire/ -- Vifor Fresenius Medical Care Renal P... |
| Apr 24, 2026 | Kurma Partners: €215 Million Biofund IV Closes As Total AUM Reach €1 Billion | Kurma Partners, a Paris-based European healthcare venture capital firm and Eurazeo group company, has announced the final closing of Biofund IV at €215 million, bringing total assets under management across all Kurma Partners franchises to ... |
| Feb 10, 2026 | Shares of Australian biotech major CSL plunge to 8-year low after CEO departure, weak earnings | CSL announced the exit of Paul McKenzie as chief executive.
Senior executive Gordon Naylor appointed interim CEO.
Shares of Australian biotech firm CSL plunged to an 8-year low Wednesday after it announced the exit of Paul McKenzie as chief... |
| Feb 9, 2026 | Memo Therapeutics enters into a collaboration with CSL |
Under the Collaboration and Option Agreement, Schlieren-based Memo Therapeutics AG (MTx) will develop recombinant polyclonal IgG products, leveraging its proprietary DROPZYLLA® technology platform for cloning human antibody repertoires and... |
| Feb 2, 2026 | 3 Ways Health Brands Can Design Digital Experiences That Users Won’t Abandon | According to new research, nearly half of users ultimately abandon the digital health or wellness technologies they adopt. This startling finding reveals a major challenge amid the industry’s rapid growth.
Health and wellness technologies a... |
| Dec 4, 2025 | 2026 set to be a milestone year for Qinecsa as drug safety tech trailblazer Beena Wood joins as Chief Product Officer | Beena will build on the pure-bred pharmacovigilance specialist's deep domain expertise and technology-powered solution portfolio to help reframe the contribution of drug safety
LONDON, Dec. 4, 2025 /PRNewswire-PRWeb/ -- Qinecsa, the gl... |
| Oct 29, 2025 | Bridge Alliance welcomes du as member operator to collaborate on IoT commercial opportunities in the UAE | SINGAPORE, Oct. 29, 2025 /PRNewswire/ -- Bridge Alliance, the leading mobile alliance globally, welcomes du as its member operator in the United Arab Emirates (UAE). Both organisations signed a membership agreement at the recent GITEX GLOBA... |
| Oct 27, 2025 | CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE) | Setting new standards in responsible innovation, CSL's Broadmeadows facility blends Pharma 4.0™ principles with sustainable design to transform plasma manufacturing
BROADMEADOWS, AUSTRALIA, Oct. 27, 2025 /PRNewswire/ -- CSL's base... |
| Sep 26, 2025 | Trump slaps new US tariffs on drugs, trucks and furniture | Trump slaps new US tariffs on drugs, trucks and furniture
By David ShepardsonSeptember 26, 20258:36 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
SummaryCompanies
Trump cites national security... |
| Sep 26, 2025 | European, Asian drugmaker shares drop after Trump imposes tariffs | European, Asian drugmaker shares drop after Trump imposes tariffs
By Gregor Hunter and Andrew SilverSeptember 26, 20256:58 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Item 1 of 2 The logo of... |
| Sep 26, 2025 | CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy | FILSPARI® (sparsentan) suggested for IgA Nephropathy patients who are at risk of progressive kidney function loss
ST. GALLEN, Switzerland, and SAN DIEGO, Sept. 26, 2025 /PRNewswire/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX... |
| Sep 16, 2025 | EQT Life Sciences portfolio company VarmX partners with CSL in a strategic collaboration and option agreement worth up to USD 2.2 billion | EQT Life Sciences portfolio company VarmX partners with CSL in a strategic collaboration and option agreement worth up to USD 2.2 billion
Tue, Sep 16, 2025 14:00 CET Report this content
VarmX is developing a bypass agent to restore coagulat... |
| Sep 1, 2025 | World Anemia Awareness Launches Global Educational Campaign on Maternal Blood Health | Their potential starts with their mother's health. New global campaign aims to protect 70,000 lives through maternal blood health education.
9 Day Global Campaign Featuring International Healthcare Experts Reaching 70 Million People Wo... |
| Aug 6, 2025 | Raising a Child with Hemophilia: Sixth Edition Now Available! | "Raising a Child with Hemophilia" Sixth Edition
Parenting a child with hemophilia is difficult in any circumstance, but less so with access to a comprehensive guide that carefully walks parents through each stage of their child... |
| Jul 28, 2025 | Brandon Capital: Fund Six Closed At Over A$439 Million | Brandon Capital, Australasia’s leading life sciences venture capital firm, has announced the final close of its sixth fund, the Brandon BioCatalyst Fund Six (BB6), totaling A$439 million. New investors in BB6 include the Western Australia G... |
| Jul 17, 2025 | Australian stocks hit record high amid mixed trading in Asia-Pacific markets | This is CNBC’s live blog covering Asia-Pacific markets.
Australian equities notched a record high as Asia-Pacific traded mixed after Wall Street gains on the back of strong U.S. economic data reports and a slew of better-than-expected corpo... |
| Jun 18, 2025 | RFK Jr.’s new vaccine advisors will vote on flu shots containing mercury | A revamped government panel of vaccine advisors appointed by Health and Human Services Secretary Robert F. Kennedy Jr. will soon vote on a shot preservative that contains mercury, which is safely used in some flu jabs but has been incorrect... |
| Apr 29, 2025 | CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy | European Commission converts conditional approval of FILSPARI (sparsentan) into standard marketing authorization for the treatment of IgA Nephropathy (IgAN)
Decision follows positive recommendation from Committee for Medicinal Products for ... |
| Dec 5, 2024 | The Unraveling of COVID-19 Narratives: A Deep Dive into the Truth | The COVID-19 pandemic reshaped the world. It turned everyday life upside down. Masks became symbols of safety, while lockdowns felt like a necessary evil. But as time passed, questions arose. A recent report from the U.S. House of Represent... |
| Dec 5, 2024 | Former CSL CEO Paul Perreault appointed strategic adviser to Microbio | Establishing sepsis diagnostic InfectID™ as the new standard of care
BRISBANE, Australia, Dec. 5, 2024 /PRNewswire/ -- Microbio Ltd, the Australian pathogen diagnostics company specialising in innovative molecular diagnostic solutions, has ... |
| Oct 17, 2024 | CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy | Temporary marketing authorization is based on statistically significant and clinically meaningful results from the phase-III PROTECT trial
ST. GALLEN, Switzerland and SAN DIEGO, Oct. 17, 2024 /PRNewswire/ -- CSL Vifor and Travere Therapeuti... |
| Oct 10, 2024 | Kurma Partners: First Closing Of €250 Million Biofund IV | Kurma Partners, an asset manager focused on improving human health, announced that it has raised EUR 140 million, completing the first closing of Biofund IV. By the final closing in 2025, Kurma aims to have raised a total of €250 million in... |
| Oct 4, 2024 | Igniting Futures: The Power of STEM Exploration Day | In a world where technology reigns supreme, the future hinges on innovation. The Children's Museum of Indianapolis recognized this truth by hosting STEM Exploration Day, a vibrant event designed to inspire young girls to embrace career... |
| Oct 3, 2024 | Kurma Partners raises €140 million first close of new €250 million Biofund IV | Paris-based Kurma Partners, an asset manager focused on improving human health, announced that it has raised €140 million, successfully completing the first closing of Biofund IV. Kurma aims to have raised a total of €250 million in its new... |
| Oct 3, 2024 | Revealed: The top 10 companies claiming the most R&D tax expenditure in Australia | Source: SmartCompany article-article-body
Tech unicorn Atlassian reported $200 million in research and development (R&D) expenditure in 2021-2022, topping the Australian Taxation Office’s first public list of entities claiming the R&... |
| Jul 25, 2024 | The Bird Flu Dilemma: A Call for Action in the U.S. Dairy Industry**
** | ** The bird flu is knocking at the door of the U.S. dairy industry. It’s a silent threat, creeping in with the stealth of a shadow. Colorado is ground zero, grappling with an outbreak that has already claimed millions of chickens and raised... |
| Jul 22, 2024 | Finland is offering farmworkers bird flu shots. Some experts say the US should, too | “Now is the time to offer the vaccines to farmworkers in the United States,” said Nahid Bhadelia, director of the Boston University Center on Emerging Infectious Diseases. Even more urgent measures are lagging in the U.S., she added. Testin... |
| Jul 9, 2024 | CSL Seqirus Begins Shipping Its Portfolio of Influenza Vaccines for the 2024/25 Flu Season | CSL Seqirus is the only manufacturer to offer a differentiated influenza vaccine for all eligible people aged six months and older in the United States.
Centers for Disease Control and Prevention (CDC) trend findings indicate a significant ... |
| Jul 1, 2024 | Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA | Strategic acquisition will enable Genezen to deliver late-phase and commercial gene therapy development and manufacturing services to customers around the world.
BOSTON and INDIANAPOLIS, July 1, 2024 /PRNewswire/ -- Genezen, a best-in-class... |
| Jun 17, 2024 | Careium launches unparalleled connectivity resilience with state-of-the-art rSIM ® technology. | Careium launches unparalleled connectivity resilience with state-of-the-art rSIM ® technology.
Mon, Jun 17, 2024 13:51 CET Report this content
Careium, the European innovation leader in technology-enabled care, now enabling customers and us... |
| May 31, 2024 | CSL Seqirus to make bird flu vaccine in Holly Springs | CSL Seqirus, a global vaccine maker with a massive manufacturing plant in Holly Springs, has won a federal contract to produce a stockpile of vaccines in case of a pandemic of avian influenza, or bird flu.
Under terms of the $22 million con... |
| May 7, 2024 | NETGEAR Brings WiFi 7 to its Flagship Orbi Family, Unleashing Elite Connectivity | NETGEAR Orbi 970 Series boasts elegant, new design, high-performance antennas and groundbreaking Enhanced Dedicated Backhaul
HONG KONG SAR – Media OutReach Newswire – 7 May 2024 – NETGEAR®, Inc. (NASDAQ: NTGR), the leading provider of award... |
| Apr 18, 2024 | Mini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build "Australia's next CSL" | MELBOURNE, Australia, April 18, 2024 /PRNewswire/ -- Australia's newest biotech incubator Jumar Bioincubator has officially opened its doors and revealed the first 16 innovative early-stage ventures to take up residency in its much-awa... |
| Jun 22, 2023 | "Jumar Bioincubator" calls for next-gen biotechs, appoints new GM | SYDNEY, June 22, 2023 /PRNewswire/ -- Australia's newest biotech incubator is calling for innovative early-stage Australian biotechs to take up residency in its much-awaited Melbourne-based facility.
The "Jumar Bioincubator" ... |
| Feb 7, 2022 | From the Athletic Field to the Research Lab ― How Uplifting Athletes is Supporting the Rare Disease Community | Six of nine rare disease researchers who received Uplifting Athletes grants pictured here with Executive Director Rob Long (left) and GM Brett Brackett (right). "We believe these all-star scientists deserve to be lauded with the same e... |
| Jan 13, 2022 | Uplifting Athletes Announces Young Investigator Draft Class of 2022 | 2022 Young Investigator Draft We believe these all-star scientists deserve to be lauded with the same excitement afforded to college and professional athletes, many of whom partner closely with us to support our mission,” said Rob Long, Exe... |
| Dec 6, 2021 | CSL : Tax Transparency Report 2021 | CSL Limited Tax Transparency Report 2020/21
The people and science of CSL save lives. Our 25,000 employees develop and deliver innovative medicines that help people in more
than 100 countries with serious and life-threatening conditions liv... |
| May 6, 2021 | CSL LIMITED
CSL : Behring Announces Agreement with uniQure | CSL Behring Announces Global Commercialization and License Agreement with uniQure
Etranacogene dezaparvovec (AMT-061) is an investigational gene therapy that may potentially provide people with hemophilia B with years of functional levels o... |
| Mar 31, 2021 | Uplifting Athletes Presents $140,000 in Rare Disease Research Grants at 2021 Young Investigator Draft | Uplifting Athletes Young Investigator Draft Presented by CSL Behring
PHILADELPHIA (PRWEB) March 31, 2021
Uplifting Athletes, a nonprofit organization serving the Rare Disease Community, awarded $140,000 in medical research grants last night... |
| Jul 15, 2020 | Two Out of Three Rare Disease Patients in Asia-Pacific Do Not Receive the Best-available Care, According to an Economist Intelligence Unit Survey | Knowledge of rare diseases among healthcare professionals is lacking:
o 34% do not know if there is a definition for rare diseases o 35% do not know if there is a national rare disease policy
14% of healthcare professionals report never enc... |
| Apr 16, 2020 | Covid-19 vaccine tracker updated to include GSK/Sanofi collaboration | By Jeff Craven
Currently, there are no FDA-approved therapies or vaccines for SARS-CoV-2, the virus that causes Covid-19. The National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes... |
| Apr 9, 2020 | Covid-19 Tracker updates vaccine candidates | By Jeff Craven
On March 11, the World Health Organization classified the Covid-19 outbreak as a pandemic. The disease has reached nearly every country, infecting hundreds of thousands of people and killing thousands.
Curr... |